Medicine and Dentistry
Breast Cancer
100%
Neoplasm
42%
Triple Negative Breast Cancer
41%
BRCA1
36%
Patient
31%
Malignant Neoplasm
27%
Therapeutic Procedure
22%
Metastatic Carcinoma
20%
Gene
18%
Chemotherapy
15%
Woman
15%
PARP Inhibitor
14%
BRCA2
13%
Breast
13%
Clinical Trial
12%
Olaparib
12%
Phenotype
12%
Disease
12%
Cells
12%
Biological Marker
10%
Analysis
10%
Inpatient
9%
Platinum
8%
Assessment
8%
Combination Therapy
8%
Primary Tumor
7%
Cancer Cell
7%
Follow up
6%
Basal Like Breast Cancer
6%
Hormone Receptor
6%
Systemic Therapy
6%
Tumor Infiltrating Lymphocyte
6%
Homologous Recombination
6%
Biological Product
6%
Distant Metastasis
6%
Somatic Mutation
6%
B Cell
6%
Neoadjuvant Chemotherapy
5%
Consensus
5%
T Cell
5%
Lymph Node Metastasis
5%
DNA Repair
5%
Surgery
5%
Ovarian Cancer
5%
Poly ADP Ribose Polymerase
5%
Contralateral
5%
Lymphoid Cell
5%
Cancer Risk
5%
Stem Cell
5%
Tumor Cell
5%
Biochemistry, Genetics and Molecular Biology
Mutation
47%
Nested Gene
40%
BRCA1
39%
Poly ADP Ribose Polymerase
34%
BRCA2
32%
Cancer Cell
24%
Homologous Recombination
23%
DNA
15%
DNA Repair
15%
Electric Potential
13%
Genome Instability
11%
Phenotype
11%
Estrogen Receptor
10%
Development
10%
Association
9%
Drive
9%
Somatic Mutation
9%
Clinical Trial
8%
Sample
7%
Classification
7%
Growth
7%
Survival
7%
Synthetic Lethality
7%
DNA Damage
7%
Time
7%
Oncogene
6%
Kinase
6%
Protein
6%
Epidermal Growth Factor Receptor
6%
Cell Death
6%
Centrosome
5%
Tumor-Infiltrating Lymphocytes
5%
Genetics
5%
Protein Expression
5%
Germline
5%
Stem Cell
5%
Cadherin
5%
Mitogen-Activated Protein Kinase
5%
Immunology and Microbiology
Breast
28%
Monospecific Antibody
11%
Cells
11%
Immunity
11%
Cancer Cell
8%
B Cell
8%
Development
8%
Antibody Drug Conjugate
7%
Lymph Node
7%
Conjugation
5%
Innate Lymphoid Cell
5%
